摘要:
A method of feeding an aquaculture of an aquatic animal species of interest is provided. The method comprising providing the aquaculture with an aquaculture feed comprising a sub- optimal dose of protein and an effective amount of butyric acid or salt thereof, the effective amount facilitating reducing feed conversion ratio (FCR). Also provided are feed compositions for aquaculturing.
摘要:
A method of minimizing fat accumulation in a growing animal without limiting caloric intake or preventing or treating obesity in an animal, the method comprising orally administering a ketogenic diet and a nutrient blend to the animal. The nutrient blend can include at least four nutrients selected from the group consisting of walnut, maitake mushroom extract, EGCG, turmeric root powder, lycopene, taurine, EPA, and DHA to the animal.
摘要:
The present invention pertains to a composition comprising iron (II) carbonate and a digestible binder, wherein the composition comprises crystals of iron(II) carbonate, which are agglomerated with the digestible binder to form digestible agglomerated particles. Also disclosed is a method of preparation of such composition, as well as uses of such composition.
摘要:
The present invention refers to controlled-release coated non-protein nitrogen (NPN) food composition, which provides the features of controlled release and complete metabolism. The present invention further provides a process for the preparation of said food composition. The food composition according to the present invention comprises a central core with 80 to 90% wt NPN and multilayer coating comprising at least four layers.
摘要:
The invention relates to a method for producing a raw piece of reconstituted meat and to a raw piece of reconstituted meat combined according to the method. Many known reconstituted meat products are rejected because they contain chemical additives such as aminases; they are expensive to produce, because the meat first is reconstituted and stabilized and is then preserved; and reconstituted meat combinations often have an inhomogeneous appearance and may tend to separate out their constituents. In order to overcome these disadvantages, a reconstituted meat composition contains only glycerol and salt as the binders, is stabilized and preserved by drying in a single step in a method for producing a raw piece of reconstituted meat and provides a combined raw piece of reconstituted meat the main constituents of which contain only meat ingredients from animal origin, it has the appearance of pure meat, and has a similar elasticity and a precise residual juice content. The raw piece of reconstituted meat can be utilized as food, particularly preferred as pet food, the latter is advantageous in that the reconstituted meat in this combination, despite having the appearance of pure fillet, can include all types of meat of a prey and therefore much better reflects the natural diet of a carnivorous pet.
摘要:
The present invention relates to synthetic bis esters of hederagenin, and their use in ruminants to improve ruminant growth performance, reduce rumen methane emission, reduce urine ammonia excretion, and/or to reduce rumen acetate to propionate ratio. Moreover, it also relates to a feed composition for ruminants comprising bis esters of hederagenin, and to novel bis esters of hederagenin.
摘要:
The present invention refers to a glycerol ester composition comprising the reaction product obtained from reacting valeric acid and glycerol at a molar ratio of between 1:0.8 and 1:1.2, for use in reduction and/or inhibition of the growth of gram-positive, pathogenic bacteria. The present invention also refers to said glycerol ester composition for use in prevention and/or alleviation of necrotic enteritis in the gastric tract of galloanserans.
摘要:
Die vorliegende Erfindung betrifft Astaxanthinzusammensetzungen zur Verwendung in Nahrungsmitteln, Nahrungsergänzüngsmitteln oder Futtermitteln oder als Medikament. (Formel (A)). Astaxanthinzusammensetzungen, die wenigstens 50 Gew.-%, insbesondere wenigstens 60 Gew.-%, besonders bevorzugt wenigstens 70 Gew.-% und speziell wenigstens 80 Gew.-% oder wenigstens 90 Gew.-%, bezogen auf das Gesamtgewicht an Astaxanthin und Astaxanthinderivaten in der Zusammensetzung, einen Monoester des Astaxanthins mit einer C18-1 -Fettsäure enthalten, weisen eine besonderes gute Bioverfügbarkeit auf. Sie eignen sich daher in besonderer Weise für den Einsatz in Nahrungsmitteln, Nahrungsergänzüngsmitteln oder Futtermitteln sowie zur therapeutischen Verwendung als Medikament sowie als Inhaltsstoff für medizinische Zubereitungen bzw. pharmazeutische Mittel.